BIN1-interactome in Alzheimer's disease pathophysiology

BIN1-相互作用组在阿尔茨海默病病理生理学中的作用

基本信息

批准号：
10677190
负责人：
Joseph McMillan
金额：
$ 3.79万
依托单位：
UNIVERSITY OF SOUTH FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-14 至 2025-08-13
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10677190
关键词：
Address Adult Affect Age Alternative Splicing Alzheimer&apos s Disease Alzheimer&apos s disease model Alzheimer&apos s disease pathology Alzheimer&apos s disease patient Alzheimer&apos s disease risk American Amyloidosis Bioinformatics Biological Process Biotin Biotinylation Brain Brain Diseases Cellular biology Clathrin Cluster Analysis Complement Core Facility Coupled Data Analyses Development Disease Dynamin Elderly Endocytosis Environment Enzymes Experimental Designs Functional disorder Future Genes Genetic Gliosis Health Human Immunofluorescence Immunologic Immunoprecipitation In Vitro Interdisciplinary Study Investigation Kinetics Knowledge Label Laboratories Late Onset Alzheimer Disease Learning Ligase Link Mass Spectrum Analysis Mediating Mentors Methods Mus Muscle Development Nature Neighborhoods Neuroblastoma Neurodegenerative Disorders Neurons Pathogenesis Pathogenicity Pathology Pathway interactions Protein Isoforms Proteins Proteome Proteomics Radial Recycling Research Research Training Retrieval Risk Risk Factors SYNJ1 gene Severities Skeletal Muscle Synapses Synapsins Synaptic Vesicles System Therapeutic Translating Translations Tumor Suppressor Proteins Wild Type Mouse Work age related neurodegeneration anticancer research apolipoprotein E-4 brain tissue detection method experimental study genetic risk factor genome wide association study grasp gray matter human old age (65+)in vivo innovation interest lifestyle factors molecular pathology mouse model neuroblastoma cell neuron loss novel pre-doctoral promoter protein protein interaction protein purification superresolution microscopy tau Proteins tool vesicular release

项目摘要

PROJECT SUMMARY Alzheimer’s disease (AD) is a devastating neurodegenerative disorder with no definitive treatment that reverses the course of the disease, and we still lack a firm grasp on how older people develop AD. Bridging Integrator 1 (BIN1) is the second-largest genetic risk factor for late-onset AD. At least 12 different alternatively spliced BIN1 isoforms are expressed in the brain, including the neuron-specific BIN1 isoform 1 (BIN1iso1) and the ubiquitously expressed BIN1 isoform 9 (BIN1iso9). In the brain gray matter of patients with AD, there is a decrease in neuronal BIN1iso1 and an increase in BIN1iso9 compared to healthy controls. Thus far, evidence has shown that neuronal BIN1 isoforms participate in clathrin-mediated endocytosis, endocytic recycling, and synaptic vesicle release and retrieval. However, the mechanisms by which BIN1 contributes to these functions and the neighborhood of proteins that BIN1 interacts with to accomplish these cellular tasks remain largely undefined. Therefore, a fundamental gap in the field is an unbiased characterization of BIN1iso1 interacting proteins and proximal neighbors. Closing this gap will help define BIN1’s biological functions in healthy and diseased brain neurons. Utilizing the highly innovative proximity biotin ligase, TurboID, fused to BIN1iso1, will allow the identification of all proteins within a 10-nm radius. TurboID-based proximity labeling coupled with the most recent advanced quantitative mass spectrometry and data analysis methods represents a powerful strategy for discovery research. My preliminary in vitro studies using this approach in mouse N2a neuroblastoma cells resulted in the discovery of 234 proteins as BIN1-associated (proximal) or interacting proteins. These results identified several known BIN1 interactors such as tau, dynamin, synaptojanin, and many previously unknown proximal proteins. The following Specific Aims will translate these findings in vivo and dramatically advance the field. Aim 1. Identify neuronal BIN1iso1 interacting proteins in vivo using wild-type mice under homeostatic conditions. Aim 2. Establish neuronal BIN1iso interactome in mouse models of AD (5XFAD and PS19) before and after the onset of pathology. This project will not only advance the field by providing those studying AD and BIN1 with a list of BIN1iso1 proximal proteins to generate novel hypotheses but will also support the applicant’s pre-doctoral research training in AD pathophysiology, advanced methods such as in vivo AAV transduction, proximity-based labeling in the context of AD pathology, large-scale proteomics data analysis, and bioinformatics analysis of BIN1 functional pathways. The dynamic and highly collaborative research environment at the USF Health Byrd Alzheimer’s Institute will enhance the learning opportunities in cell biology and molecular pathology within an established AD laboratory led by a committed mentor. Furthermore, research training in proteomics approaches offered by the collaborator’s lab and the Proteomics Core facilities will complement the applicant’s interdisciplinary research training in age-related neurodegenerative disease.

项目概要阿尔茨海默病 (AD) 是一种毁灭性的神经退行性疾病，目前尚无明确的治疗方法可以逆转疾病的病程，我们仍然缺乏对老年人如何发展 AD 的确切了解。 (BIN1)是迟发性AD的第二大遗传风险因素，至少有12种不同的选择性剪接BIN1。同工型在大脑中表达，包括神经元特异性 BIN1 同工型 1 (BIN1iso1) 和普遍存在的 AD患者大脑灰质中表达的BIN1异构体9（BIN1iso9）的神经元数量减少。迄今为止，有证据表明，与健康对照相比，BIN1iso1 和 BIN1iso9 有所增加。 BIN1 亚型参与网格蛋白介导的内吞作用、内吞再循环和突触小泡释放和然而，BIN1 贡献这些功能的机制和邻域。 BIN1 与 BIN1 相互作用以完成这些细胞任务的蛋白质在很大程度上仍不清楚。该领域的根本差距是 BIN1iso1 蛋白相互作用和的公正表征缩小这一差距将有助于确定 BIN1 在健康和患病大脑中的生物学功能。利用高度创新的邻近生物素连接酶 TurboID，与 BIN1iso1 融合，将允许识别 10 纳米半径内的所有蛋白质，基于 TurboID 的邻近标记加上最新的标记。先进的定量质谱和数据分析方法代表了一种强有力的策略我在小鼠 N2a 神经母细胞瘤细胞中使用这种方法进行了初步的发现研究。结果发现了 234 个蛋白质作为 BIN1 相关（近端）或相互作用蛋白质。结果确定了几种已知的 BIN1 相互作用因子，例如 tau、dynamin、synaptojanin 以及许多以前的相互作用因子以下具体目标将在体内显着地转化这些发现。目标 1. 使用野生型小鼠体内鉴定神经 BIN1iso1 相互作用蛋白。目标 2. 在 AD 小鼠模型（5XFAD 和 PS19）在病理发生之前和之后该项目不仅将通过提供这些来推进该领域。使用一系列 BIN1iso1 近端蛋白研究 AD 和 BIN1，以产生新的假设，但也将支持申请人在 AD 病理生理学、体内 AAV 等先进方法方面接受过的博士前研究培训转导、AD 病理学背景下的基于邻近性的标记、大规模蛋白质组学数据分析，以及 BIN1 功能通路的生物信息学分析。动态且高度协作的研究环境。南佛罗里达大学健康伯德阿尔茨海默病研究所将增加细胞生物学和分子生物学的学习机会在由一位忠诚的导师领导的已建立的 AD 实验室内进行病理学此外，还进行了研究培训。合作者实验室和蛋白质组学核心设施提供的蛋白质组学方法将补充申请人在与年龄相关的神经退行性疾病方面的跨学科研究培训。